Why Cettire, Gold Road, Imugene, and Paladin Energy shares are racing higher

These shares are ending the week with a bang. But why? Let's find out.

| More on:
A smiling businessman in the city looks at his phone and punches the air in celebration of good news.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is fighting hard to end the week on a positive note. In afternoon trade, the benchmark index is up 0.4% to 8,232.7 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

Cettire Ltd (ASX: CTT)

The Cettire share price is up 3.5% to $1.62. This is despite there being no news out of the online luxury products retailer. However, with its shares down over 40% since this time last year and 67% from their 52-week high, it seems that some investors believe that a buying opportunity has been created.

Gold Road Resources Ltd (ASX: GOR)

The Gold Road share price is up almost 3% to $2.12. This follows a decent night of trade for the gold price on Wall Street. According to CNBC, the gold futures price was up over 1% to US$2,668.8 an ounce during overnight trade on safe haven demand. This meant that the precious metal climbed to a two-week high. It isn't just Gold Road Resources that is rising today. The S&P/ASX All Ordinaries Gold index is up 2.5% at the time of writing.

Imugene Ltd (ASX: IMU)

The Imugene share price is up 2.5% to 4 cents. This morning, this immuno-oncology company released an update on its phase 1b clinical trial of its allogeneic CAR T-cell therapy azer-cel at the Royal Prince Alfred Hospital (RPAH) in Sydney. It is focused on patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), which is one of the most challenging and aggressive forms of non-Hodgkin's lymphoma. According to the release, the first Australian patient has been dosed in the Phase 1b clinical trial at the RPAH. Imugene CEO, Leslie Chong, said: "Achieving first patient dosed for azer-cel in Australia represents a significant milestone for Imugene and for Australian patients battling this devastating disease."

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is up 8% to $8.53. A number of ASX 200 uranium stocks are racing higher on Friday after industry giant Cameco announced the suspension of production at its joint venture with Kazatomprom. Cameco stated: "We are disappointed and surprised by this unexpected suspension and we will be seeking further clarification on how this transpired, as well as the potential 2025 and 2026 production and financial impacts (including on future dividends), and what Cameco can do to help Kazatomprom and JV Inkai restart mining operations."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Three happy multi-ethnic business colleagues discuss investment or finance possibilities in an office.
Financial Shares

The IAG share price soared 50% in 2024! Here's how

IAG shares smashed the benchmark returns in 2024. But how?

Read more »

Best Shares

Which ASX 200 large-cap shares outperformed their peers in 2024?

We reveal the 16 best ASX 200 large-cap stocks for share price growth last year.

Read more »

Three happy girls on jumping motion with inflatable mattresses at the beach.
Share Gainers

3 ASX All Ords shares leading the charge in 2025

These ASX All Ords shares have soared 16% to 37% already in 2025.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Insignia, Rio Tinto, St Barbara, and Structural Monitoring shares are rising today

These shares are ending the week on a positive note. But why? Let's find out.

Read more »

A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
Small Cap Shares

2 ASX small-cap shares rocketing 35% to 54% today

Two soaring ASX small-cap shares are setting the bar high on Friday.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Arcadium Lithium, Bellevue Gold, Catalyst Metals, and Northern Star shares are rising today

These shares are having a good session on Thursday. But why? Let's find out.

Read more »

A group of people at a party look upwards to the camera as they celebrate the rise of ASX value shares
Share Gainers

16 ASX shares that doubled in value last year

There were multiple ASX All Ords stocks that delivered double-or-more share price growth in 2024.

Read more »

A woman blows what looks like colourful dust at the camera, indicating a positive or magic situation.
Share Gainers

Why Deterra, DroneShield, Regis Resources, and West African shares are storming higher

These shares are having a strong session on hump day. Why are investors buying them?

Read more »